Junyuan Petroleum Group cordially invites you to join us at CPhI Japan 2026 in Tokyo, where we will present our high-purity n-Heptane solutions designed to empower the global pharmaceutical supply chain.
📅 Event Details
Date: April 21–23, 2026 Location: Tokyo, Japan Scale: Japan’s largest pharmaceutical ingredients exhibition, covering 26,000 sqm, gathering 528 exhibitors and 19,681 professional visitors. Past Data: 400–500 exhibitors (40% domestic, 60% international from China, India, Europe, and the U.S.); 8,000+ professional attendees, including top Japanese pharma companies such as Takeda and Daiichi Sankyo.
Market Opportunities in Japan: High-End Demand Meets n-Heptane Applications
1. Japan’s Pharmaceutical Market Position
The world’s third-largest pharmaceutical market with an API market size of USD 37.2 billion in 2024. Over 70% of high-end APIs rely on imports, with China as a primary supplier. Tokyo hosts the headquarters of industry leaders such as Eisai and Takeda, accounting for more than 40% of Japan’s API market and serving as a hub for R&D and trade in advanced ingredients.
2. Core Applications of n-Heptane in Pharma
Drug Synthesis Solvent: Ideal for extraction, reaction medium, and purification processes, meeting Japan’s stringent pharmaceutical standards. Biopharmaceutical Support: Plays a critical role in mRNA vaccine production and biosimilar development (e.g., anti-PD-1 therapies). Regulatory Advantage: With full REACH certification, n-Heptane helps Japanese firms overcome international trade barriers and aligns with the government’s push for “antibiotic API localization.”
Junyuan Petroleum Group’s n-Heptane Advantages
1. REACH-Certified Compliance
Fully compliant with EU environmental, health, and safety standards. Provides global market access and ensures Japanese customers benefit from a secure and compliant supply chain.
2. Technical Strength & Versatility
High Purity Grades: Suitable for pharmaceutical processes including solvents, extractants, and analytical reagents (HPLC). Broad Applications: Aligns with CPhI Japan’s exhibition scope, covering excipients, stabilizers, nucleic acid purification, and biopharma R&D.
3. Tailored Services for Japan
Customized technical solutions to meet local requirements. Strong support for CDMO collaborations and innovative drug development.
Driving Innovation and Partnerships
At CPhI Japan 2026, Junyuan Petroleum Group will demonstrate how our REACH-certified n-Heptane is more than a solvent — it is a trusted enabler of pharmaceutical innovation, compliance, and international cooperation.
We look forward to building stronger partnerships with Japanese pharmaceutical leaders and contributing to the next wave of global healthcare solutions.
📍 Meet us in Tokyo – April 21–23, 2026.
#Heptane #Pharma #REACH #APIs #Pharmaceuticals #CPhI #Japan #Biopharma #Healthcare